Exhaled Breath Condensate Biomarkers and Cough in IPF
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Idiopathic Pulmonary Fibrosis
Related studies linked through entity extraction aliases.
Clinical Progression of Mild to Moderate Idiopathic Pulmonary Fibrosis (IPF) Under a Therapy With Esbriet® (Pirfenidone)
- Status
- COMPLETED
- Phase
- N/A
First Time in Human (FTIH) Study of GSK3008348 in Healthy Volunteers and Idiopathic Pulmonary Fibrosis Patients
- Status
- COMPLETED
- Phase
- PHASE1
All-Case Surveillance of Ofev in Patients With IPF in Japan
- Status
- COMPLETED
- Phase
- N/A
A Study to Compare the Amount of Nintedanib and Pirfenidone in the Blood When Nintedanib and Pirfenidone Are Given Separately or in Combination
- Status
- COMPLETED
- Phase
- PHASE4
Home-Based Pulmonary Rehab for Patients With Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- NA
Safety and Tolerability Study of Pirfenidone in Combination With Nintedanib in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety, Tolerability and PK of Nintedanib in Combination With Pirfenidone in IPF
- Status
- COMPLETED
- Phase
- PHASE4
Observational Study to Evaluate Disease Course and Outcomes in Patients Treated With Esbriet (Pirfenidone) for Idiopathic Pulmonary Fibrosis (IPF) in Canada
- Status
- COMPLETED
- Phase
- N/A
High Oxygen Delivery to Preserve Exercise Capacity in Idiopathic Pulmonary Fibrosis Patients Treated With Nintedanib
- Status
- COMPLETED
- Phase
- NA
A Trial to Evaluate the Efficacy of PRM-151 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
- Status
- COMPLETED
- Phase
- PHASE2
Responsiveness and MID of 4 Metre Gait Speed in Idiopathic Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- N/A
Safety, Tolerability, and Efficacy of MN-001 (Tipelukast) in Patients With Idiopathic Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Gefapixant (AF-219/MK-7264) in Participants With Idiopathic Pulmonary Fibrosis (IPF) With Persistent Cough (MK-7264-016)
- Status
- COMPLETED
- Phase
- PHASE2
68Ga-BMV101 PET/CT in Patients With Idiopathic Pulmonary Fibrosis
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Using MRI to Visualize Regional Therapy Response in Idiopathic Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Assess the Tolerability of a Single Dose of Gefapixant (AF-219/MK-7264) in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
- Status
- COMPLETED
- Phase
- PHASE2
Cyclophosphamide for Acute Exacerbation of Idiopathic Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- PHASE3
Reliability of the 4 Metre Gait Speed in Idiopathic Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- N/A